Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients
Clinical trial NCT00558493 · COMPLETED
Trial details
- NCT number
- NCT00558493
- Sponsor
- Bukwang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.